CDKN3 and breast carcinoma: To further explore the impact of iodoacetate on cell cycle progression of breast cancer cells, we assessed its effect on the mRNA expression of the cyclin-dependent kinase inhibitors p21 and p27 proteins that control cell cycle progression and cell death response.